News

Photo

Hempel Buys Cap Couleurs Store Network

Danish coatings company Hempel has acquired Cap Couleurs’ store network in southeastern France, maintaining its segment leadership in the Var region and supporting its growth initiatives. Financial terms were not disclosed.

Photo

Calum MacLean to Head Lanxess-Advent JV

German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for high-performance engineering plastics.

Photo

Koch and Ioniqa Partner on PET Recycling Technology

Koch Technology Solutions, the licensing arm of Koch Engineered Solutions, is partnering Ioniqa Technologies, a Dutch clean-tech spinoff from the Eindhoven University of Technology, to scale up and commercialize the latter’s advanced PET recycling process.

Photo

Henkel Buys NBD Nanotechnologies

Henkel has acquired US advanced materials start-up NBD Nanotechnologies for an undisclosed sum. Headquartered in Boston, Massachusetts, NBD specializes in developing coatings and additives with surface wettability.

Photo

Stepan Buys Surfactants from PerformanX

US specialty chemicals company Stepan has agreed to acquire the surfactant business and associated assets of compatriot firm PerformanX Specialty Chemicals. The purchase will include intellectual property, commercial relationships and inventory.

Photo

Global Amines Commissions Indonesia Plant

Singapore’s Global Amines – a joint venture between compatriot company Wilmar and Switzerland’s Clariant – has successfully started up a new fatty amines plant in Surabaya, Indonesia.

Photo

WuXi Opens Lipid Nanoparticle Facility

WuXi STA has opened a sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its campus in Wuxi city, China, in response to rising demand for complex injection dosage forms.

Photo

IMCD Buys Japan’s Kuni Chemical

IMCD has taken over Japanese specialty distribution company Kuni Chemical for an undisclosed sum. Kuni specializes in industrial applications that range from coatings and construction to automotive and packaging materials.

Photo

Hovione Expands Continuous Manufacturing Capabilities

Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers a commercial continuous tableting platform to support their key needs.

Photo

Germany’s Merck Expands French Facility

German science and technology company Merck has announced plans to invest more than €130 million at its site in Molsheim, France, to expand capacities for single-use assemblies, a key technology for producing Covid-19 vaccines and other therapies.

Photo

Novartis to Shutter a Sandoz US Plant

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US plants.

Photo

Lonza and Touchlight Collaborate on DNA

Lonza has entered into a collaboration with Touchlight, a biotechnology company with patented technology for producing enzymatic DNA. The enzymatic manufacturing process is said to enable GMP production at “unprecented speed, scale and purity.”

Photo

BASF Commissions Solar Farm at Schwarzheide

BASF Schwarzheide, subsidiary of the German-multinational chemical group, together with local east German utility company Envia Mitteldeutsche Energie, has commissioned the region’s first solar farm. The project was announced by BASF last year as part of its plans to focus on renewable energy for its chemical production.

Photo

SK Closes Sale of NuCera Solutions to Chase

An affiliate of funds advised by SK Capital Partners has completed the sale of NuCera Solutions to international specialty chemicals company Chase Corp. for $250 million. The companies entered into the agreement on Jul. 18.

Photo

Eurotecnica Wins More Melamine Contracts

Eurotecnica, the technology arm of energy firm and major methanol producer Proman, has announced the award of two large contracts for implementing high-pressure melamine plants.

Photo

US Drugmaker Merck & Co. to Add Jobs in Ireland

US drugmaker Merck & Co. plans to add 100 new jobs as part of an expansion project at its site in Carlow, Ireland, which opened in 2008 as the company’s first vaccines facility outside of the US and currently employs 530 people.

Photo

BASF, SABIC and Linde Start Building Demo E-cracker

BASF, SABIC and Linde have started building a plant to demonstrate using electricity instead of natural gas to heat steam cracker furnaces. The move follows the signing of a joint agreement in March 2021 to develop and demonstrate solutions for electrifying steam crackers.

Photo

Novartis Sued over its own Drug

Swiss drugmaker Novartis, already embroiled in a number of lawsuits against generics producers seeking to create copies of its blockbuster cardiac insufficiency treatment Entresto, is now itself being sued.

Photo

EMA’s CHMP Greenlights Omicron-1 Vaccines

The human medicines committee (CHMP) of EU drug regulator European Medicines Agency (EMA) has recommended approval of the updated Covid-19 vaccines of Pfizer-BioNTech and Moderna, combining protection against the original Omicron variant as well as the wild type that emerged in China in early 2020.

Photo

BASF to Collaborate with Sulzer ChemTech

Germany’s BASF and Swiss-based technology firm Sulzer Chemtech have announced plans to collaborate on finding sustainable solutions for a number of industrial applications, in particular renewable fuels and chemically recycled plastics.

Photo

Clariant Sells Quats to Global Amines

Clariant has agreed to sell its quats business to Singapore’s Global Amines for $113 million. Global Amines is a 50:50 joint venture between Clariant and Singapore-based agricultural and oleochemicals company Wilmar.

Photo

Novo Nordisk Boosts Blood Disorders with Forma Buy

Danish pharma Novo Nordisk has agreed to acquire US clinical-stage biopharma Forma Therapeutics in a deal worth $1.1 billion that will expand its blood disorders portfolio. Forma’s board of directors has unanimously approved the takeover, which is expected to close in the final quarter of 2022.

12171 more News

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.